Carboxyfullerene neuroprotection postinjury in Parkinsonian nonhuman primates

Authors:

Abstract
Objective: We evaluated the efficacy of the potent antioxidant C3 to salvage nigrostriatal neuronal function after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) exposure in nonhuman primates. C3 is a first‐in‐class functionalized water‐soluble fullerene that reduces oxygen radical species associated with neurodegeneration in in vitro studies. However, C3 has not been evaluated as a neuroprotective agent in a Parkinson model in vivo.Methods: Macaque fascicularis monkeys were used in a double‐blind, placebo‐controlled study design. MPTP‐lesioned primates were given systemic C3 (n = 8) or placebo (n = 7) for 2 months starting 1 week after MPTP. Outcomes included in vivo behavioral measures of motor parkinsonism using a validated nonhuman primate rating scale, kinematic analyses of peak upper extremity velocity, positron emission tomography imaging of 6‐[18F]fluorodopa (FD; reflects dopa decarboxylase) and [11C]dihydrotetrabenazine (DTBZ; reflects vesicular monoamine transporter type 2), ex vivo quantification of striatal dopamine, and stereologic counts of tyrosine hydroxylase–immunostained neurons in substantia nigra.Results: After 2 months, C3‐treated monkeys had significantly improved parkinsonian motor ratings, greater striatal FD and DTBZ uptake, and higher striatal dopamine levels. None of the C3‐treated animals developed any toxicity.Interpretation: Systemic treatment with C3 reduced striatal injury and improved motor function despite administration after the MPTP injury process had begun. These data strongly support further development of C3 as a promising therapeutic agent for Parkinson disease. Ann Neurol 2014;76:393–402
Funding Information
  • National Institutes of Health (NS039913)
  • National Institutes of Health (NS05425)
  • National Institutes of Health (AG033679)
  • National Institutes of Health (R21AG030320)
  • National Institutes of Health (NS37688)
  • National Institutes of Health (NS058714)
  • Larry L. Hillblom Foundation
  • National Institutes of Health (NS075321)
  • American Parkinson Disease Association
  • Barnes-Jewish Hospital Foundation
  • Greater St. Louis Chapter of the American Parkinson Disease Association
  • McDonnell Center for Higher Brain Function
  • Selma I. Hartke bequest

This publication has 32 references indexed in Scilit: